Medical startup Anges Inc. said Tuesday it has started Japan's first clinical trial on humans of a potential vaccine for the new coronavirus, aiming for government approval by the fall next year for its sale if the vaccine proves to be safe and effective.The trial at Osaka City University Hospital begins with injecting the DNA vaccine into 30 healthy adults through early July. It will assess their data over eight weeks to see whether they have side effects from the vaccine or have developed antibodies against the disease.The participants are grouped into two teams of 15, with one given larg…READ FULL ARTICLE
